Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Articulus Bio was a private, development-stage orthopedic medical device company based in Boulder, Colorado focused on next-generation total joint replacement. Its core technology, the Tendonoid Web Joint, was designed to reduce polyethylene wear debris and friction at articulating joint surfaces, a major cause of orthopedic implant failure. The company's lead application was a total ankle replacement device, with additional planned applications in cervical and lumbar artificial disc implants and potentially other joints. Articulus Bio raised seed financing from AngelMD in early 2018 to support device development, FDA Q-Submission planning, and intellectual property expansion. Available sources indicate the company later ceased operations and its Colorado entity was voluntarily dissolved.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Articulus Bio.